Cryptocurrency investors are reacting with both hope and fear as the markets are increasingly reacting to US President Donald Trump’s threats and hopes on geopolitical issues. Ethereum fell about 6.5% to below $3,000, while Solana dropped more than 4% yesterday and almost 12% last week, as crypto traders exercise caution amid Trump’s arbitrary announcements that could affect their investments. On the other hand, Bitcoin rebounded to about $90,000 as the crypto stabilised amid a modest rebound in the US equity futures markets. Overall, the crypto market has been deeply affected by President Trump’s renewed tariff threats towards European countries as…
Author: Abizar Attari
Abizar Attari
Abizar has been writing before AI started to take over your lives! His expertise lies in analysing diverse perspectives and simplifying them for laymen. Beyond writing, storytelling and editing, he enjoys running, learning and enjoying the outdoors.
Read More
Tokyo: Japanese electronics giant Sony Group has announced a strategic partnership with China’s TCL Electronics to continue manufacturing its iconic, premiumised Bravia range of TVs. This development comes at a time when increasing competition has reduced the margins, even as manufacturers come up with premiumised versions to stand out. “We are pleased to have reached this agreement with TCL for a strategic partnership. By combining both companies’ expertise, we aim to create new customer value in the home entertainment field, delivering even more captivating audio and visual experiences to customers worldwide,” Kimio Maki, President and CEO, Sony Corporation, said in…
Mumbai: BigBloc Construction has reported a 28.1% year on year (YoY) increase in revenues for Q3 FY26 as the company returned to profitability following its efforts to improve capacity utilisation and sustained demand. The company reported operating revenues of ₹728 million in Q3 FY26, while the gross profit was at ₹426 million, a 21.5% year on year increase. Besides that, the company’s Profit After Tax (PAT) was at ₹4 million, a 53.9% increase from last year. BigBloc has improved its capacity utilisation to 90% overall in Q3 FY26, even as the utilisation at its Building Elements subsidiary was at 63%…
Mumbai: Satin Creditcare Network’s subsidiary, Satin Technologies Limited (STL), will acquire a majority 76.40% stake in QTrino Labs Pvt Ltd as the company aims to boost its technology stack, the company said in a press release. The IIT incubated deep tech startup develops cost-effective, cutting-edge and quantum-safe security solutions for government and enterprise clients. Its advanced cybersecurity capabilities align well with STL’s long-term vision. The proposed acquisition will help STL expand its business footprint in the advanced technology and cybersecurity domains, with QTrino becoming a subsidiary of STL after the due diligence is done. With QTrino, Satin Creditcare gains an…
Mumbai: Mastek Ltd has reported a 11.2% quarter-on-quarter (QoQ) increase in net profit at ₹108.4 crore for Q3 FY26, as the IT services firm continues to benefit from strong demand for AI-enabled deals and an expanding client base. The company has secured more than 26 AI deals during the quarter, enhancing its revenues that had declined by 3.7% QoQ in rupee terms due to furloughs and delays in projects’ go-lives for its clients in the US and Asia. During the quarter, the company secured lucrative contracts from government and non-government clients in the UK, the US and Australia to meet…
New Delhi: Vardhaman Special Steels has reported a net profit decline of 8.06% for Q3 FY26 as rising input costs and increased competitiveness have weighed in on margins. Following the announcement, the company’s shares plunged nearly 5%, as investors grew concerned over the company’s ability to face economic challenges. Revenues for the quarter remained muted at ₹430.54 crore as against ₹426.77 crore in the same period last year, mostly attributed to higher sales volumes. The company’s EBITDA was at ₹56.47 crore in the quarter, as against ₹42.05 crore last year, an increase of 34.28%. Over the quarter, the company recorded…
New Delhi: ITC Hotels Ltd, one of India’s leading hospitality companies, has reported a 21% year on year rise in consolidated revenue for Q3 FY26 even as the company actively renovates some of its properties and expands aggressively. This quarter, ITC Hotels surpassed the 150 hotel milestone, as the company looks to become the leading hospitality chain in the country. The company reported operational revenues of Rs.1,231 crore, 21% more than last year, with its Profit After Tax (PAT) being 42% higher YoY at Rs.307 crore. The company’s room revenues increased by 12% for its corporate, wedding and MICE segments,…
Mumbai: Senores Pharmaceuticals reported a significant year-on-year surge in its Profit After Tax (PAT) for Q3FY26 increasing 105% to ₹34 crores even as the company’s shares plunged following the news. The shares have decreased mostly due to ongoing strategic developments at the company, as it is in the middle of completing its acquisition of Apnar Pharmaceutical, which is expected to close by Q2 FY27. The company’s revenues increased 64% to ₹175 crores, heavily supported by its emerging markets business that grew about 48% on a year on year basis. The company’s EBITDA for the quarter was also at a healthy…
New Delhi: Ksolves India Ltd has posted a 12.2% year on year increase in revenue for Q3 FY26 on the back of steady demand for its digital transformation and technology service offerings. The company is aiming to reach growth of about 20% for the fiscal year 2026, with these results helping the company in that regard. For its quarterly revenue of ₹42.3 crore, the company reported a Profit After Tax (PAT) of ₹9.8 crore, with a PAT margin of 23.2%. Ksolves’s EBITDA margin has also increased to 32.8% this quarter, from 30.4% recorded in the previous quarter. Along with this,…
Mumbai: India’s largest pharmaceutical company, Sun Pharmaceuticals, has placed a non-binding offer of about $10 billion to acquire US-based women’s health and speciality pharma company Organon. If this deal goes through, it could become one of the largest acquisitions ever by an Indian pharmaceutical company. Organon offers a wide portfolio of products to diagnose women’s health issues related to infertility, menopause, breast cancer, polycystic ovarian syndrome (PCOS) and others, besides its portfolio of biosimilars. Spun out of MSD (Merck Sharp & Dohme) in 2021, Organon has made several acquisitions over the years, including Forendo Pharma in 2021 and Dermavant in…
